Clinical trials
alpha-Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitari Vall d'Hebron Research Institute | 2 |
| University of California, San Francisco | 2 |
| Bristol-Myers Squibb | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Cyprus Institute of Neurology and Genetics | 1 |
| Deborah Rund | 1 |
| Forma Therapeutics, Inc. | 1 |
| HaEmek Medical Center, Israel | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| alpha-Thalassemia | 16 |
| beta-Thalassemia | 8 |
| Anemia, Sickle Cell | 7 |
| Hemoglobinopathies | 6 |
| Thalassemia | 6 |
| Anemia | 4 |
| Anemia, Diamond-Blackfan | 2 |
| Anemia, Hemolytic | 2 |
| Cystic Fibrosis | 2 |
| Cystinosis | 2 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.